Oslo Medtech can in June 2011 look back on their first 1 ½ years as a constantly growing and developing cluster. We used the occasion to ask the board chairman, Carl Christian Gilhuus-Moe, to sum up the results of the activity so far, and to look in-to the future of Oslo Medtech.
- The board of Oslo Medtech is most satisfied with the development and results achieved in Oslo Medtech after their first one and a half years.
The many breakfast meetings organized under the umbrella title ‘Hidden Diamonds of Norwegian Medtech’ have gained enormous support with an increasing number of attendees. The meetings have been a great joint arena for Medtech and eHealth, gathering people from companies, research, hospitals, investors and organizations. They have all interacted at these meetings, and thereby got to know each other better, and shared ideas and projects. I’m both astonished, and also a bit proud, by the huge number of excellent Norwegian Medtech companies that have surfaced on these networking arenas. Oslo Medtech will do its utmost to try to give better attention as support and also more support attention to this growing industry , both nationally and internationally.
Oslo Medtech first major achievement :The USA Medtech Market Insight Meeting in beginning of April put an important focus on the potential, barriers, regulatory affairs and market drivers in the US Healthcare Market. The meeting gained a very good attendance from the Norwegian Medtech industry, something that the overbooking of the one2one meetings on the day 2 of the conference confirmed.
The people and companies attending gained a great deal of important knowledge about how to enter the US Health Care Market, and also built direct relations to excellent advisors. The event also played a very important role in the building of the “bridge” towards the US Midwest region – the Medtech hub no. 1 in the world, and in building an important network for Oslo Medtech and its members of highly qualified advisors in reimbursement, FDA regulations, financing mechanisms, and strategic and market drivers.
- As a follow up Oslo Medtech and a group of companies attended the Midwest Investor Conference and a Oslo Medtech networking event in Minneapolis in mid May this year.
Thanks to Karl Øyri, the Intervention Center, OUS, for photograps from Minneapolis-events
The team of US Medtech advisors that spoke at the USA Medtech Meeting in Oslo in April had set up lots of meetings for the visiting Norwegian companies, also introducing them to possible partners. Oslo Medtech and the Norwegian companies achieved great exposure at the events, and gained a lot of attention and support from companies, network, advisors, politicians and investors in the Mid West.
- A long time dream has come through: This ‘bridge’ between Mid West/USA and Norway/Oslo, built by Oslo Medtech and its members, means that people, technology, companies, advisors and ideas easily can flow between USA and Norway, and be of help for both US and Norwegian companies in their strive for obtaining CE and FDA marks, getting their products on the US or the European market, building the value of their companies. I would specially like to express a great thanks to Kermit Nash in Minneapolis and his network of advisors for helping Oslo Medtech achieving all of this after only one and a half years in business.
- The Oslo Medtech General Assembly took place June 16th 2011 with good attendance from our members. The General Assembly elected the new board and election committee, and Mr. Helmut Straubinger, CEO and President in JenaValve in Munich, held the Oslo Medtech Speach 2011. JenaValve is in the process of getting CE-mark approval in the field of TAVI ( Trans Appical Valve Inplantment), Helmut Straubinger gave us a most personal presentation of how to build a company from an idea and research result in to a million dollar company in short time. See Event Archive/General Assembly Meeting & summerparty 2011
The Oslo Medtech Summerparty and networking event which finished off the General Assembly provided an excellent platform for good and interesting medtech talks and the building of new and useful relations. The Chairman's observation is that truly what was not expressed in formal part of the General Assembly, turned out to be expressed over the many round tables during the dinner session.
Isn’t it a shame that you who didn’t come ?
Oslo Medtech now has about 100 members, and Mr. Carl Christian Gilhuus-Moe is very pleased to see that companies and organizations from the whole value chain of the Medtech and eHealth industry are represented in the growing cluster.
- A huge number of the members are very active, supporting and participating in a lot of the activities and the events of Oslo Medtech. The comments from the different member groups on the development of Oslo Medtech are also very satisfying and indeed supporting
Oslo Medtech will in the fall of 2011 start the discussion of the future strategy for the Oslo Medtech undertaking. We want the members to actively participate in this discussion, and will in the fall of 2011 set up meetings, workshops and events – open for all the members.